| Literature DB >> 18404373 |
Xuan Wang1, Xi-Bin Liang, Feng-Qiao Li, Hui-Fang Zhou, Xian-Yu Liu, Jian-Jun Wang, Xiao-Min Wang.
Abstract
In China, it has been estimated that there are more than 2.0 million people suffering from Parkinson's disease, which is currently becoming one of the most common chronic neurodegenerative disorders during recent years. For many years, scientists have struggled to find new therapeutic approaches for this disease. Since 1994, our research group led by Drs. Ji-Sheng Han and Xiao-Min Wang of Neuroscience Research Institute, Peking University has developed several prospective treatment strategies for the disease. These studies cover the traditional Chinese medicine-herbal formula or acupuncture, and modern technologies such as gene therapy or stem cell replacement therapy, and have achieved some original results. It hopes that these data may be beneficial for the research development and for the future clinical utility for treatment of Parkinson's disease.Entities:
Mesh:
Substances:
Year: 2008 PMID: 18404373 DOI: 10.1007/s11064-008-9691-z
Source DB: PubMed Journal: Neurochem Res ISSN: 0364-3190 Impact factor: 3.996